Slime production and antibiotic susceptibility in staphylococci isolated from clinical samples

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 1, 2007, Pages 29-33

  Arslan, Seza ^a   Özkardeş, Fatma ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Antimicrobial susceptibility; Clinical isolates; Slime; Staphylococcus sp.; lactamase

Indexed keywords

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SP.;

EID: 33847149359     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762007000100004     Document Type: Article

References (33)

1. Ammendolia MG, Di rosa R, Montanaro R, Arciola CR, Baldassarri L 1999. Slime production and expression of the slime-associated antigen by staphylococal clinical isolates. J Clin Microbiol 37: 3235-3238.
2. Baselga R, Albizu L, De La Cruz M, Del Cacho E, Barberan M, Amorena B 1993. Phase variation of slime production in Staphylococcus aureus: implications in colonization and virulence. Infect Immun 61: 4857-4862.
3. Boyce JM 1990. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 11: 639-642.
4. Caputy GG, Costerton JW 1982. Morphological examination of the glycocalyses of Staphylococcus aureus strains Wiley and Smith. Infect Immun 36: 759-767.
5. Christensen GD, Simpson WA, Bisno AL, Beachey EH 1982. Adherence of slime producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 37: 318-326.
6. Davenport DS, Massanari RM, Pfaller MA, Bale MJ, Streed SA, Hierholzer WJ 1986. Usefulness of a test for slime production as a marker for clinically significant infections with coagulase negative staphylococci. J Infect Dis 153: 332-339.
7. Diaz-Mitoma F, Harding GKM, Hoban DJ, Roberts RS, Low DE 1987. Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulasenegative staphylococci. J Infect Dis 156: 555-560.
8. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M and the SENTRY Participants Group 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pasific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32: S114-S132.
9. Etienne J, Brun Y, Solh NE, Delorme V, Mouren C, Bes M, Fleurette J 1988. Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocardatis. J Clin Microbiol 26: 613-617.
10. Freeman DJ, Falkiner FR, Keane CT 1989. New method for detecting slime production by coagulase negative staphylococci. J Clin Pathol 42: 872-874.
11. Fux CA, Uehlinger D, Bodmer T, Droz S, Zellweger C, Muhlemann K 2005. Dynamics of hemodialysis catheter colonization by coagulase-negative staphylococci. Infect Cont Hosp Ep 26: 567-574.
12. Gemmel CG 1986. Coagulase-negative staphylococci. J Med Microbiol 22: 285-295.
13. Gold HS, Moellering RC 1996. Drug therapy: antimicrobial-drug resistance. New Engl J Med 335: 1445-1453.
14. Gristina AG, Hobgood CD, Webb LX, Myrvik QN 1987. Adhesive colonization of biomaterials and antibiotic resistance. Biomaterials 8: 423-426.
15. Hackbarth CJ, Chambers HF 1989. Methicillin-resistant staphylococci: detection methods and treatment of infections. Antimicrob Agents Chemother 33: 995-999.
16. Hsueh PR, Teng LJ, Chen WH, Pan HJ, Chen ML, Chang SC, Luh KT, Lin FY 2004. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother 48: 1361-1364.
17. Hussain Z, Stoakes L, Garrow S, Longo S, Fitzgerald V, Lannigan R 2000. Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test. J Clin Microbiol 38: 2051-2054.
18. Ishak MA, Groschel DH, Mandell GL, Wenzel RP 1985. Association of slime with pathogenicity of coagulase-negative staphylococci causing nosocomial septicemia. J Clin Microbiol 22: 1025-1029.
19. Khatib R, Riederer KM, Clark JA, Khatib S, Briski LE, Wilson FM 1995. Coagulase-negative staphylococci in multiple blood cultures: strain relatedness and determinants of same strain bacteremia. J Med Microbiol 33: 816-820.
20. Kleeman KT, Bannerman TL, Kloos WE 1993. Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures. J Clin Microbiol 31: 1318-1321.
21. Kloss WE, Bannerman TL 1994. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 7: 117-140.
22. Kluytmans JAJW, Wertheim HFL 2005. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33: 3-8.
23. Mack KD, Bartscht S, Dobinsky MA, Horskotte H, Kiel K-M, Knobloch A, Schafer P 2000. Staphylococcal factors involved in adhesion and biofilm formation on biometarials. In YH An, RJ Friedman (eds), Handbook of Bacterial Adhesion. Principles Methods and Applications, Humana Press, Totowa, NJ, p. 307-330.
24. Marshall SA, Pfaller MA, Jones RN 1999. Ability of the modified vitek card to detect coagulase-negative staphylococci with mecA and oxacillin resistant phenotypes. J Clin Microbiol 37: 2122-2123.
25. Massanari RM, Pfaller MA, Wakesfield DS, Hammons GT, McNut LA, Woolson RF, Helms CM 1988. Implications of acquired oxacillin resistance in the management and control of Staphylococcus aureus infections. J Infect Dis 158: 702-709.
26. Montanari MP, Tonin E, Biavasco F, Varaldo PE 1990. Further Characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding protein. Antimicrob Agents Chemother 34: 911-913.
27. Muller E, Takeda S, Shiro H, Goldmann DA, Pier GB 1993. Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci. J Infect Dis 168: 1211-1218.
28. NCCLS-National Committee for Clinical Laboratory Standards 1997. Performance standards for antimicrobial disk susceptibility tests. Approved Standard, M2-A6, Wayne, PA.
29. Rupp ME, Archer GD 1994. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis 19: 231-245.
30. Salmenlinna S, Lyytikainen O, Vuopio-Varkila J 2002. Community acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis 8: 602-607.
31. Sorrell TC, Packham DR, Shanker S, Foldes M, Munro R 1982. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med 97: 344-350.
32. Tenover FC, Gaynes RP 2000. The epidemiology of Staphylococcus infections. In VA Fishetti, RP Novick, JJ Ferretti, DA Portnoy, JI Rood (eds), Gram-positive Pathogens, ASM Press, Washington DC, p. 414-421.
33. Urdez-Hernandez E, Sifuentes-Osornio J, Calva JJ, Villalobos-Zapata Y 1999. Epidemiological and biological characteristics of methicillin-resistant staphylococcal infections in a Mexican Hospital. Arch Med Res 30: 325-331.